Newsroom

Blog

Liquid Biopsies

Despite the terminology “liquid biopsies” (LBx) becoming common place in diagnostic lexicon, as a routine clinical technology, LBx is still very much in its infancy.

Read More
Written By:
JamesYen.jpg
James Yen

TriCon 2021 Perspective

It was no surprise that Molecular Med Tri-Con 2021 was a virtual event this year.

Read More
Written By:
JamesYen.jpg
James Yen

Why does IHC remain so popular for CDx development?

The topic of IHC came up recently. Specifically, why is it used so frequently for companion diagnostic development.

Read More
Written By:
scottreid.jpg
Scott Reid

New China operation

December 30th was an exciting day for NeoGenomics as we got the keys to our new facility in Suzhou, China.

Read More
Written By:
GeorgeCardoza.jpg
George A. Cardoza

CRO and Clinical Reference Laboratory Commercial Incentives

One of the challenges developing a companion diagnostic is creating a test that runs well in both clinical trials, and following regulatory approval, clinical testing laboratories Unfortunately, in

Read More
Written By:
scottreid.jpg
Scott Reid

Oncology Clinical Trials During a Pandemic

2020 has really been a year that doesn’t quit, hasn’t it?

Read More
Written By:
MadhuGhosh.jpg
Madhu Ghosh

It’s a Great Clinical Trial Assay

While there are many great tools and technologies available to support drug development, the number of platforms used for CDx development remains very limited.

Read More
Written By:
scottreid.jpg
Scott Reid

Is It Validated?

NeoGenomics has a menu of >600 assays across many different technologies and approaches.

Read More
Written By:
scottreid.jpg
Scott Reid

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients